Vaccine for children: Expert Panel Recommends Nod To SII for Phase 2, 3 Trials Of Covovax

India is likely to start trials of another vaccine, Covovax, on kids. The Subject Expert committee (SEC) on Tuesday recommended granting permission to Serum Institute of India for conducting Phase two and three trials of the vaccine on children aged 2 to 17 with certain conditions.

.

Visit www.werindia.com OR Hindi.werindia.com to read news from 500+ news sources... आपका अपना डिजिटल अख़बार |

 
• 28 Jul 2021
• WerIndia